Larimar Therapeutics, Inc. logo

LRMRLarimar Therapeutics, Inc.

LRMR Stock Price, Valuation & Chart | Larimar Therapeutics, Inc.

Compare

LRMR Historical price chart

LRMR Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization402.03M
PE Ratio-1.98
EPS-1.95
Trading Volume515.26K
Today's High/Low4.08/3.83
Dividend Yield0.00
52 Week High/Low6.42/2.71
Shares Outstanding103.88M
LRMR Financial Statement
LRMR Analyst ratings
LRMR Analysis & performance metrics

LRMR Company profile

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology…

LRMR Management team

Management
Michael Celano CPACFO
Secretary & Chief Financial Officer
Russell G. Clayton Sr., D.O, D.O.
Chief Medical Officer
Gopi Shankar M.B.A., Ph.D.
Chief Development Officer
Jennifer Spokes Johansson
Vice President of Legal & Compliance
Carole S. Ben-Maimon M.D.CEO
Chief Executive Officer, President & Director
John Berman
Vice President of Finance & Administration
Francis Michael Conway CPA
Vice President & Controller
Total 7 executives

LRMR Frequently asked questions

What is Larimar Therapeutics, Inc. (LRMR) Stock Price?

Current stock price of Larimar Therapeutics, Inc. (LRMR) stock is $3.870. The stock price is -1.78% lower in the session. The intraday range can be seen from this page. Volume of Larimar Therapeutics, Inc. (LRMR) stock is 515.26K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Larimar Therapeutics, Inc. (LRMR) stock price going up or down today?

The stock price of Larimar Therapeutics, Inc. (LRMR) can change with earnings, company news, and overall market sentiment. Larimar Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Larimar Therapeutics, Inc. stock expensive at its current price?

Whether Larimar Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for LRMR on this page is -1.98. EPS on this page is -1.95. Compare those figures with peers and growth expectations before deciding if the current Larimar Therapeutics, Inc. price is justified.

How has the stock price of Larimar Therapeutics, Inc. (LRMR) performed historically?

Historical performance for Larimar Therapeutics, Inc. (LRMR) is shown on the price chart on this page. Review multi-period moves alongside volume to see how LRMR reacted to past earnings and market events.

Should I buy Larimar Therapeutics, Inc. (LRMR) stock, at this price?

Buying Larimar Therapeutics, Inc. (LRMR) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.